Public Health Agency of Canada
Symbol of the Government of Canada

Share this page

CIPARS 2007 - Final Report

Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS)

Appendix B – Additional Tables continued

The following information are important for the interpretation of tables presenting results on the distribution of minimum inhibitory concentrations (MIC; Appendix B.1 and B.2).

  • Roman numerals I to IV indicate the ranking of human medicine importance as outlined by the Veterinary Drugs Directorate.
  • The unshaded fields indicate the range tested for each antimicrobial in the plate configuration.
  • Bold red numbers indicate the percentage of isolates that were resistant to the antimicrobial according to the predefined resistance breakpoint.
  • Numbers to the right of the highest concentration in the tested range (i.e. bold red numbers in shaded fields) represent the percentage of isolates with growth in all wells within the tested range, indicating that the actual MICs were greater than the tested range of concentrations.
  • Numbers at the lowest concentration in the tested range (i.e. blue numbers at the far left in unshaded fields) represent the percentage of isolates susceptible to the antimicrobial at the indicated or lower concentrations.
  • Solid bars represent resistance breakpoints.
  • Dotted bars represent susceptibility breakpoints.
  • MIC 50 = MIC at which 50% of isolates were inhibited.
  • MIC 90 = MIC at which 90% of isolates were inhibited.
  • %R = Percentage of isolates that were resistant.

Table B.2.12. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from pigs; Farm Surveillance, 2007.
Table B.2.12. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from pigs; Farm Surveillance, 2007.

Table B.2.12. - Text Equivalent

Table B.2.13. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from pigs; Abattoir Surveillance, 2007.
Table B.2.13. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from pigs; Abattoir Surveillance, 2007.


Table B.2.13. - Text Equivalent

Table B.2.14. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from pigs; Surveillance of Animal Clinical Isolates, 2007.
Table B.2.14. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from pigs; Surveillance of Animal Clinical Isolates, 2007.

Table B.2.14. - Text Equivalent

Table B.2.15. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Escherichia coli isolates from pigs; Farm Surveillance, 2007.
Table B.2.15. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Escherichia coli isolates from pigs; Farm Surveillance, 2007.

Table B.2.15. - Text Equivalent

Table B.2.16. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Escherichia coli isolates from pigs; Abattoir Surveillance, 2007.
Table B.2.16. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Escherichia coli isolates from pigs; Abattoir Surveillance, 2007.

Table B.2.16. - Text Equivalent

Table B.2.17. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Escherichia coli isolates from pork, by province; Retail Meat Surveillance, 2007.
Table B.2.17. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Escherichia coli isolates from pork, by province; Retail Meat Surveillance, 2007.

Table B.2.17. - Text Equivalent

Table B.2.18. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Enterococcus isolates from pigs, by Enterococcus species; Farm Surveillance, 2007.
Table B.2.18. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Enterococcus isolates from pigs, by Enterococcus species; Farm Surveillance, 2007.

a Resistance to quinupristin-dalfopristin and lincomycin is not reported for E. faecalis because E. faecalis is intrinsically resistant to these antimicrobials.

Table B.2.18. - Text Equivalent

Table B.2.19. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from turkeys; Surveillance of Animal Clinical Isolates, 2007.
Table B.2.19. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from turkeys; Surveillance of Animal Clinical Isolates, 2007.

Table B.2.19. - Text Equivalent

Table B.2.20. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from horses; Surveillance of Animal Clinical Isolates, 2007.
Table B.2.20. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from horses; Surveillance of Animal Clinical Isolates, 2007.

Table B.2.20. - Text Equivalent

Table B.2.21. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from feed; Surveillance of Feed and Feed ingredients, 2007.
Table B.2.21. Distribution of minimum inhibitory concentrations (MICs; μg/mL) for antimicrobials in Salmonella isolates from feed; Surveillance of Feed and Feed ingredients, 2007.

Table B.2.21. - Text Equivalent

B.3 Antimicrobial Use in Humans


Table B.3.1. Total volume of active ingredients of oral antimicrobials dispensed by retail pharmacies in Canada, 2000–2007.
    ATC Class Total amount of active ingredients (Kg)
2000 2001 2002 2003 2004 2005 2006 2007
I J01CR Combinations of penicillins, including ß-lactamase inhibitors 7,148.28 7,295.71 7,114.06 7,492.67 7,491.56 8,414.31 8,985.63 9,798.46
J01DD Third-generation cephalosporins 441.47 412.56 372.50 321.45 275.37 282.37 274.85 303.36
J01MA Fluoroquinolones 17,387.35 17,569.37 17,718.15 18,469.28 18,738.69 18,781.31 19,348.84 19,788.30
J01XA Glycopeptides 25.90 28.25 32.23 40.56 70.36 79.17 75.77 83.99
J01XD Imidazole NA 4,808.34 4,927.11 5,126.54 5,237.51 5,311.07 5,563.98 5,585.72
J01XX Linezolid NA 1.55 4.91 10.82 17.29 23.26 22.44 25.35
II J01CA Penicillins with extended spectrum 57,566.37 56,004.37 53,404.23 53,132.75 51,471.46 53,138.73 53,534.56 53,440.34
J01CE ß-lactamase sensitive penicillins 15,079.86 14,253.92 13,722.26 13,802.13 12,916.80 13,174.53 13,139.62 12,879.95
J01CF ß-lactamase resistant penicillins 8,351.00 8,004.27 7,376.34 7,135.18 6,596.38 5,861.06 5,604.86 5,157.50
J01DB First-generation cephalosporins 16,693.30 17,295.99 18,358.43 19,683.24 20,312.94 21,585.02 22,981.10 23,345.75
J01DC Second-generation cephalosporins 11,099.40 9,857.59 8,712.26 8,570.41 8,277.23 8,410.81 7,937.42 7,423.47
J01EE Combinations of sulfonamides and trimethoprim, Including derivatives 26,196.41 23,815.65 21,549.97 20,179.30 19,226.17 18,858.59 18,520.09 18,079.24
J01FA Macrolides 25,163.98 23,844.04 21,665.44 22,138.28 21,168.11 22,746.49 22,646.85 22,513.36
J01FF Lincosamides 3,289.35 3,590.12 3,896.00 4,272.26 4,441.95 4,499.59 4,976.71 5,303.12
J01GB Aminoglycosides 29.66 0.36 0.04 0.00 0.01 NA 0.05 0.20
J01MB Other quinolones, excluding fluoroquinolones 76.31 62.19 52.12 45.35 41.87 1.05 0.26 0.02
J01RA Sulfonamide combinations, excluding trimethoprim 2,745.17 1,910.05 1,251.28 843.14 548.87 494.05 418.86 305.33
J01XC Steroid antimicrobials 34.79 39.06 35.54 37.27 36.64 41.91 42.73 34.21
III J01AA Tetracyclines 14,112.37 13,169.24 12,595.12 11,902.77 11,050.90 10,709.61 10,298.35 9,664.96
J01BA Amphenicols 0.78 0.99 0.20 NA 0.06 0.01 NA NA
J01EA Trimethoprim, including derivatives 315.71 297.29 310.34 307.34 288.32 265.98 265.88 260.48
J01EB Short-acting sulfonamides 105.38 13.45 0.88 1.04 1.02 0.26 0.13 0.03
J01EC Intermediate-acting sulfonamides 28.08 4.48 4.77 5.55 4.51 2.93 2.27 2.36
J01XE Nitrofuran derivatives 935.24 981.97 1,019.51 1,073.19 1,152.40 1,210.89 1,323.77 1,387.68
J01XX Fosfomycin 64.76 74.26 48.00 35.71 26.28 20.78 17.80 11.01
NC J01XX Methenamine 389.51 356.69 350.35 296.88 282.20 253.34 249.14 256.85
  J01 Total 207,280.44 203,691.77 194,522.04 194,923.13 189,674.87 194,167.12 196,231.93 195,651.06

Roman numerals I to III indicate the ranking of antimicrobials based on importance in human medicine as outlined by the Veterinary Drugs Directorate.
ATC = Anatomical Therapeutic Chemical. NA = Not available. NC = Not classified.

B.4 Summary Tables for Human and Agri-Food Data


Table B.4.1. Summary of selected resistance patterns involving multiple antimicrobials in bacterial isolates from humans and the agri-food sector; CIPARS, 2007.
Species Bacterial species Number (%) of isolates/Serovar total
Number (%) of isolates/ Salmonella total
Susceptible to all antimicrobials Resistant to A2C-AMP ACSSuT AKSSuT ACKSSuT A2C+ ACSSuT A2C+ AKSSuT A2C+ ACKSSuT
Surveillance des isolats cliniques humains
Humans Salmonella Enteritidis (n = 910) 795/910 (87%)     1/910 (< 1%)        
795/3,308 (24%)     1/3,308 (<1%)        
S. Heidelberg
(n = 319)
193/319 (60%) 46/319 (14%)       1/319 (< 1%)    
193/3,308 (6%) 46/3,308 (1%)       1/3,308 (< 1%)    
S. Newport
(n = 127)
113/127 (89%)   1/127 (1%)     2/127 (2%)   2/127 (2%)
113/3,308 (3%)   1/3,308 (<1%)     2/3,308 (<1%)   2/3,308 (<1%)
S. Typhi
(n = 156)
30/156 (19%)   16/156 (10%)          
30/3,308 (1%)   16/3,308 (< 1%)          
S. Paratyphi A and B
(n = 45)
12/45 (27%)   2/45 (4%)          
12/3,308 (<1%)   2/3,308 (<1%)          
S. Typhimurium
(n = 658)
436/658 (66%) 3/658 (< 1%) 73/658 (11%) 7/658 (1%) 12/658 (2%) 6/658 (1%)    
436/3,308 (13%) 3/3,308 (< 1%) 73/3,308 (2%) 7/3,308 (< 1%) 12/3,308 (< 1%) 6/3,308 (< 1%)    
Other Serovars
(n = 1,093)
847/1,093 (77%) 8/1,093 (1%) 3/1,093 (< 1%) 2/1,093 (< 1%) 2/1,093 (< 1%)      
847/3,308 (26%) 8/3,308 (<1%) 3/3,308 (<1%) 2/3,308 (<1%) 2/3,308 (<1%)      
Farm Surveillance
Pigs Escherichia coli (n=1,575) 219/1,575 (14%) 4/1,575 (<1%) 45/1,575 (3%) 32/1,575 (3%) 14/1,575 (<1%) 1/1,575 (< 1%)    
S. Derby (n = 21) 7/21 (33%) 7/110 (6%)     1/21 (5%) 1/110 (1%)        
S. I 4:i:- (n = 7) 3/7 (43%) 3/110 (3%)   1/ 7 (14%) 1/110 (1%)   3/7 (43%) 3/110 (3%)      
S. Typhimurium (n = 10) 7/10 (70%) 7/110 (6%)   1/10 (10%) 1/110 (1%)   5/10 (50%) 5/110 (5%)      
S. Typhimurium var. 5- (n = 22) 14/22 (64%) 14/110 (13%)   6/22 (27%) 6/110 (5%) 2/22 (9%) 2/110 (2%) 2/22 (9%) 2/110 (2%)      
S. Typhimurium var. 5- (n = 22) 0/2 (0%) 0/110 (0%)   1/2 (50%) 1/110 (1%)   1/2 (50%) 1/110 (1%)      
Abattoir Surveillance
Beef cattle E. coli (n = 188) 111/188 (59%)              
Chickens E. coli (n = 180) 42/180 (23%) 35/180 (19%)       7/180 (4%) 3/180 (2%)  
S. Enteritidis (n = 20) 19/20 (95%) 19/206 (9%)              
S. Heidelberg (n = 37) 23/37 (62%) 23/206 (11%) 7/37 (19%) 7/206 (3%)            
S. Typhimurium (n = 11) 6/11 (55%) 6/206 (3%) 2/11 (18%) 2/206 (< 1%) 3/11 (27%) 3/206 (1%)          
Other serovars (n = 138) 46/138 (33%) 46/206 (22%) 13/138 (9%) 13/206 (6%)            
Pigs E. coli (n = 93) 17/93 (18%) 1/93 (1%) 2/93 (2%) 4/93 (4%) 1/93 (1%)      
S. Heidelberg (n = 3)                
S. Typhimurium (n = 32) 4/32 (13%) 4/105 (4%)   17/32 (53%) 17/105 (16%)   4/32 (13%) 4/105 (4%)      
Other serovars (n = 70) 36/70 (51%) 36/105 (34%)       2/70 (3%) 2/105 (2%)     1/70 (1%) 1/105 (< 1%)
Retail Meat Surveillance
Beef E. coli (n = 501) 432/501 (86%)   1/501 (< 1%) 1/501 (< 1%) 1/501 (< 1%) 1/501 (< 1%)    
Chicken E. coli (n = 402) 107/402 (27%) 66/402 (16%) 2/402 (< 1%) 8/402 (2%) 1/402 (< 1%) 3/402 (< 1%) 1/402 (< 1%) 1/402 (< 1%)
S. Enteritidis (n = 17) 17/17 (100%) 17/346 (5%)              
S. Heidelberg (n = 87) 48/87 (55%) 48/346 (14%) 16/87 (18%) 16/346 (5%)            
S. Typhimurium (n = 12) 10/12 (83%) 10/346 (3%)   1/12 (8%) 1/346 (1%)          
Other serovars (n = 230) 92/230 (40%) 92/346 (27%) 18/230 (8%) 18/346 (5%)            
Pork E. coli (n = 297) 162/297 (55%) 2/297 (< 1%) 3/297 (1%) 3/297 (1%)        
Surveillance of Animal Clinical Isolates
Cattle S. Heidelberg (n = 1) 1/1 (100%) 1/140 (<1%)              
S. Typhimurium (n = 47) 19/47 (40%) 19/140 (14%)   7/47 (15%) 7/140 (5%)   10/47 (21%) 10/140 (7%) 1/47 (2%) 1/140 (< 1%)   2/47 (4%) 2/140 (1%)
Other serovars(n = 92) 85/92 (92%) 85/140 (61%)              
Chickens S. Enteritidis (n = 36) 36/36 (100%) 36/105 (34%)              
S. Heidelberg (n = 21) 11/21 (52%) 11/105 (10%) 8/21 (38%) 8/105 (8%)            
S. Typhimurium (n = 12) 11/12 (92%) 11/105 (10%)   1/12 (8%) 1/105 (<1%)          
Other serovars (n = 36) 19/36 (53%) 19/105 (18%) 5/36 (14%) 5/105 (5%)         1/36 (3%) 1/105 (<1%)  
Pigs S. Enteritidis (n = 2) 2/2 (100%) 2/187 (1%)              
S. Heidelberg (n = 1)                
S. Typhimurium (n = 104) 8/104 (8%) 8/187 (4%)   30/104 (29%) 30/187 (16%) 6/104 (6%) 6/187 (3%) 23/104 (22%) 23/187 (12%)      
Other serovars (n = 80) 36/80 (45%) 36/187 (19%) 1/80 (1%) 1/187 (< 1%) 3/80 (4%) 3/187 (2%) 4/80 (5%) 4/187 (2%) 3/80 (4%) 3/187 (2%) 2/80 (3%) 2/187 (1%)   1/80 (< 1%) 1/187 (< 1%)
Turkeys S. Enteritidis (n = 2) 2/2 (100%) 2/49 (4%)              
S. Heidelberg (n = 8) 1/8 (13%) 1/49 (2%) 2/8 (25%) 2/49 (4%)            
S. Typhimurium (n = 11) 1/11 (9%)
1/49 (2%)
10/11 (91%) 10/49 (20%)            
Autres sérotypes(n = 28) 3/28 (11%)
3/49 (6%)
9/28 (32%) 9/49 (18%)       1/28 (4%) 1/49 (2%) 2/28 (7%) 2/49 (4%)  
Horses S. Heidelberg (n = 54)                
S. Newport (n = 2) 2/2 (100%) 2/67 (3%)              
S . Typhimurium (n = 5) 3/5 (60%) 3/67 (4%)   1/5 (20%) 1/66 (2%) 1/5 (20%) 1/66 (20%)        
Autres sérotypes(n = 6) 6/7 (100%) 6/67 (7%)              

Results for each of the above specific patterns exclude isolates resistant to one of the other patterns presented in this table but may include isolates resistant to other antimicrobials. Blank cells represent values equal to zero (0%). For the purpose of this table, S. Typhimurium var. 5- results were combined with S. Typhimurium results (except for Farm Surveillance) to harmonize serovar classification with that of the National Microbiology Laboratory.





Table B.4.2. Summary of antimicrobial resistance in the most common isolates of Salmonella serovars from humans and the agri-food sector; CIPARS, 2007.
  Most common serovars
Species Total (n) Susceptible to antimicrobials 1 to 4 antimicrobials in resistance pattern 5 to 8 antimicrobials in resistance pattern 9 to 15 antimicrobials in resistance pattern
Surveillance of Human Clinical Isolates
Humans n = 3308 n = 2356 n = 763 n = 179 n = 10
Enteritidis (910) Enteritidis (725) Enteritidis (178) Typhimurium (105) Typhimurium (6)
Typhimurium (658) Typhimurium (436) Heidelberg (121) Typhi (32) Newport (3)
Heidelberg (319) Heidelberg (193) Typhimurium (111) Enteritidis (7) Choleraesuis (1)
Typhi (156) Newport (113) Typhi (94) Heidelberg (5)  
Newport (127) Thompson (92) Hadar (72) I 4,(5),12:i:- (4)  
Thompson (94) Oranienburg (77) Paratyphi A (31) Saintpaul (4)  
I 4,(5),12:i:- (83) I 5,(5),12:i:- (59) Mbandaka (23) Stanley (3)  
Oranienburg (78) Infantis (56) I 4,(5),12:i:- (20) Newport (2)  
Farm Surveillance
Pigs n = 110 n = 49 n = 36 n = 25  
Typhimurium var. 5- (22) Infantis (10) Typhimurium var. 5- (8) Typhimurium var. 5- (10)  
Derby (21) Derby (7) Typhimurium (3) Typhimurium (6)  
Infantis (11) Typhimurium var. 5- (4) I 4:i:- (3) I 4:i:- (4)  
Typhimurium (10) Orion (3) California (2)    
I 4:i:- (7) California (3) Brandenburg (2)    
California (4) I 4:-:- (2) Mbandaka (2)    
Heidelberg (4) Johannesburg (2)      
Brandenburg (3) Krefeld (2)      
Mbandaka (3) London (2)      
Orion (3) Muenchen (2)      
  Heidelberg (2)      
Abattoir Surveillance
Chickens n = 206 n = 94 n = 98 n = 14  
Kentucky (89) Heidelberg (23) Kentucky (57) Kentucky (11)  
Heidelberg (37) Kentucky (21) Heidelberg (14) Typhimurium (2)  
Enteritidis (20) Enteritidis (19) Hadar (9) Typhimurium var. 5- (1)  
Hadar (10) Kiambu (4) I4:i:- (4)    
I4:i:- (7) Thompson (4) Kiambu (2)    
Typhimurium (7) Typhimurium (4)      
Kiambu (6) I4:i:- (3)      
  Agona (2)      
  Mbandaka (2)      
  Typhimurium var. 5- (2)      
Pigs n = 105 n = 40 n = 38 n = 26 n = 1
Derby (18) Brandenburg (5) Derby (15) Typhimurium (12) I4:i:- (1)
Typhimurium (16) Infantis (5) Typhimurium var. 5- (5) Typhimurium var. 5- (10)  
Typhimurium var. 5- (16) London (5) Heidelberg (3) I4:i:- (1)  
Brandenburg (6) Derby (3) Agona (2) Mbandaka (1)  
Infantis (6) Typhimurium (3) California (2) Ohio (1)  
London (5) Give (2) I4:d:- (2) Senftenberg (1)  
Mbandaka (4) Manhattan (2) Krefeld (2)    
Agona (3) Mbandaka (2) Altona (1)    
California (3) Agona (1) Bovismorbificans (1)    
Heidelberg (3) Bredeney (1) Brandenburg (1)    
Krefeld (3) California (1) Infantis (1)    
  Havana (1) Mbandaka (1)    
  I6,7:-:5 (1) Typhimurium (1)    
  I6,7:-:z15 (1) Worthington (1)    
  Kentucky (1)      
  Krefeld (1)      
  Litchfield (1)      
  Muenchen (1)      
  Orion (1)      
  Typhimurium var. 5- (1)      
  Worthington (1)      
Retail Meat Surveillance
Chicken n = 346 n = 167 n = 169 n = 10  
Kentucky (110) Heidelberg (48) Kentucky (77) Kentucky (6)  
Heidelberg (87) Kentucky (27) Heidelberg (37) Heidelberg (2)  
Hadar (22) Enteritidis (17) Hadar (21) Kiambu (1)  
Enteritidis (17) Thompson (16) Schwarzengrund (7) Typhimurium (1)  
Thompson (16) Infantis (11) Kiambu (6)    
Kiambu (14) Typhimurium (9)      
Infantis (11) Kiambu (7)      
Typhimurium (10) Agona (4)      
Schwarzengrund (9)        
Surveillance of Animal Clinical Isolates
Cattle n = 140 n = 105 n = 13 n = 20 n = 2
Typhimurium (35) Kentucky (28) Typhimurium var. 5- (4) Typhimurium (14) Typhimurium var5- (2)
Kentucky (29) Typhimurium (19) Anatum (3) Typhimurium var. 5- (6)  
Cerro (13) Cerro (12) Typhimurium (2)    
I6,14,18:-:- (11) I6,14,18:-:- (11) Cerro (1)    
Typhimurium var. 5- (10) Thompson (6) Hadar (1)    
Thompson (6) I4:i:- (4) I4:i:- (1)    
I4:i:- (5) Schwarzengrund (4) Kentucky (1)    
Schwarzengrund (4) Infantis (3)      
Anatum (3) Montevideo (3)      
Infantis (3)        
Montevideo (3)        
Chickens n = 105 n = 77 n = 24 n = 3 n = 1
Enteritidis (36) Enteritidis (36) Heidelberg (10) Kentucky (1) Bredeney (1)
Heidelberg (21) Heidelberg (11) I8,20:-:z6 (3) Senftenberg (1)  
Kentucky (12) Typhimurium (9) Kentucky (3) Typhimurium (1)  
Typhimurium (10) Kentucky (8) I4:i:- (2)    
I4:i:- (6) I4:i:- (4) Infantis (2)    
Infantis (4) I-:gm:- (2) Braenderup (1)    
I8,20:-:z6 (3) Infantis (2) Hadar (1)    
  Typhimurium var. 5- (2) IRough-O:k:- (1)    
    Thompson (1)    
Pigs n = 187 n = 46 n = 59 n = 79 n = 3
Typhimurium (66) Derby (9) Typhimurium (21) Typhimurium (39) Ohio (2)
Typhimurium var. 5- (38) Infantis (9) Derby (12) Typhimurium var. 5- (25) Livingstone (1)
Derby (25) Typhimurium (6) Typhimurium var. 5- (11) Derby (4)  
Infantis (9) Brandenburg (3) Schwarzengrund (3) Albany (2)  
Brandenburg (6) Enteritidis (2) Agona (2) Ohio (2)  
Schwarzengrund (5) Schwarzengrund (2) Brandenburg (2)    
Mbandaka (4) Tennessee (2) Mbandaka (2)    
Ohio (4) Typhimurium var. 5- (2)      
  Worthington (2)      
  Alachua (1)      
  Anatum (1)      
  Berta (1)      
  Havana (1)      
  I-:r:5 (1)      
  I6,7:-:l,w (1)      
  London (1)      
  Mbandaka (1)      
  Soerenga (1)      
Turkeys n = 49 n = 7 n = 31 n = 8 n = 3
Typhimurium (10) Enteritidis (2) Typhimurium (9) Senftenberg (3) Bredeney (2)
Heidelberg (8) Brandenburg (1) Heidelberg (5) Agona (2) Senftenberg (1)
Senftenberg (7) Heidelberg (1) Hadar (4) Heidelberg (2)  
Agona (5) Senftenberg (1) Agona (3) Typhimurium (1)  
Hadar (4) Thompson (1) Anatum (2)    
Anatum (2) Typhimurium var. 5- (1) Derby (2)    
Bredeney (2)   I4:-:- (2)    
Derby (2)   Senftenberg (2)    
Enteritidis (2)   Albany (1)    
I4:-:- (2)   I-:eh:5 (1)    
Albany (1)        
Brandenburg (1)        
I-:eh:5 (1)        
Thompson (1)        
Typhimurium var. 5- (1)        
Horses n = 67 n = 11 n = 3 n = 53  
Heidelberg (54) Typhimurium (3) Heidelberg (3) Heidelberg (51)  
Typhimurium (5) Newport (2)   Typhimurium (2)  
Newport (2) Rubislaw (2)      
Rubislaw (2) Give (1)      
  Hartford (1)      
  I4,[5],12:b:- (1)      
  Thompson (1)      

Most common serovars were those representing 2% or more of the isolates within each surveillance component and species.





Table B.4.3. Recovery rates for bacterial species of isolates from various surveillance components of the agri-food sector; CIPARS, 2002−2007.
CIPARS Component/ Animal species Province Year % Isolates recovered          Number of isolates recovered/number of samples submitted
Escherichia coli Salmonella Campylobacter Enterococcus
Farm Surveillance
Pigs   2006 99% 459/462 20% 94/462     81% 374/462
2007 100% 612/612 21% 136/612     81% 495/612
Abattoir Surveillance
Beef cattle   2002 97% 76/78 1% 3/78        
2003 97% 155/159 < 1% 1/114        
2004 98% 167/170            
2005 97% 122/126     66% 23/35    
2006 100% 150/150     36% 31/87    
2007 99% 188/190     39% 75/190    
Pigs   2002 97% 38/39 27% 103/385        
2003 98% 153/155 28% 395/1393        
2004 99% 142/143 38% 270/703        
2005 99% 163/164 42% 212/486        
2006 98% 115/117 40% 145/359        
2007 98% 93/95 36% 105/296        
Chickens   2002 100% 40/40 13% 25/195        
2003 97% 150/153 16% 126/803        
2004 99% 130/131 16% 142/893        
2005 99% 218/220 18% 200/1103        
2006 100% 166/166 23% 187/824        
2007 99% 180/181 25% 204/808        
Retail Meat Surveillance
Beef British Columbia 2005 93% 27/29            
2007 79% 49/62            
Saskatch- ewan 2005 79% 120/151            
2006 76% 123/161            
2007 78% 118/151            
Ontario 2003 66% 101/154 2% 2/84 3% 2/76 91% 69/76
2004 80% 190/237            
2005 81% 184/227            
2006 81% 189/235            
2007 71% 184/227            
Québec 2003 57% 84/147 0% 0/33 0% 0/33 80% 28/35
2004 56% 137/245            
2005 56% 126/225            
2006 50% 109/215            
2007 68% 147/216            
Pork British Columbia 2005 31% 10/32            
2007 29% 23/79 1% 1/79        
2008 30% 44/148 2% 3/148        
Saskatch- ewan 2005 30% 48/162            
2006 30% 49/165 2% 3/134        
2007 25% 38/154 2% 3/154        
Ontario 2003 58% 90/154 1% 1/93 0% 0/76 87% 66/76
2004 71% 198/279            
2005 59% 179/303            
2006 59% 182/311 < 1% 1/255        
2007 54% 172/320 2% 6/319        
Québec 2003 42% 61/147 3% 1/32 9% 3/32 82% 28/34
2004 38% 109/290            
2005 26% 79/300            
2006 20% 57/287 0% 0/232        
2007 22% 64/287 1% 3/288        
Chicken British Columbia 2005 95% 19/20 13% 5/39 69% 27/39 100% 20/20
2007 98% 42/43 22%a 18/81 35% 28/80 100% 34/34
Saskatch- ewan 2005 98% 81/83 14% 21/153 37% 53/145 98% 83/85
2006 98% 85/86 16% 25/153 33% 51/155 98% 85/87
2007 97% 75/77 31%a 43/141 35% 49/141 100% 77/77
Ontario 2003 95% 137/144 16% 27/167 47% 78/166 99% 143/144
2004 95% 150/158 17% 54/315 45% 143/315 100% 158/158
2005 95% 145/153 9% 26/303 40% 120/303 99% 150/152
2006 97% 152/156 12% 36/311 34% 104/311 98% 154/156
2007 98% 157/161 54%a 172/320 37% 117/320 100% 161/161
Québec 2003 89% 112/126 16% 29/171 55% 94/170 100% 125/125
2004 96% 157/161 17% 53/320 50% 161/322 100% 161/161
2005 95% 142/149 9% 26/300 34% 103/299 100% 150/150
2006 94% 135//144 12% 33/288 35% 100/288 100% 144/144
2007 90% 129/144 40%a 113/287 21% 59/287 99% 143/144

Results in the gray-shaded areas indicate isolates that were recovered but not submitted for antimicrobial-susceptibility testing.

a Enhancement to Salmonella recovery method explains higher prevalence in isolates from retail chicken in 2007 than in prior years.


Table B.4.4. Distribution of animal isolates of Salmonella, by province; Surveillance of Animal Clinical Isolates, 2007.
Species Alberta Saskatchewan Manitoba Ontario Québec New Brunswick Nova Scotia
Number (%) of isolates
Cattle (n = 140) 3 (2) 1 (1) 6 (4) 90 (64) 40 (29)    
Chickens (n = 105) 10 (10)   5 (5) 67 (64) 22 (21) 1 (1)  
Pigs (n = 187) 3 (2) 3 (2) 9 (5) 85 (45) 79 (42)   8 (5)
Turkeys (n = 49) 3 (6)     19 (39) 26 (53)   1 (2)
Horses (n = 67) 2 (3)     63 (94) 2 (3)